r 64719 has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 3 studies
| Studies (r 64719) | Trials (r 64719) | Recent Studies (post-2010) (r 64719) | Studies (9-(2-hydroxy-3-nonyl)adenine) | Trials (9-(2-hydroxy-3-nonyl)adenine) | Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 428 | 1 | 33 |
| Protein | Taxonomy | r 64719 (IC50) | 9-(2-hydroxy-3-nonyl)adenine (IC50) |
|---|---|---|---|
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | 0.8 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.8 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 0.8 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cespuglio, R; Gharib, A; Reynaud, D; Sarda, N | 1 |
| Van Belle, H | 1 |
| Brause, M; Delabar, U; Eckardt, KU; Gleiter, CH; Zebski, H | 1 |
3 other study(ies) available for r 64719 and 9-(2-hydroxy-3-nonyl)adenine
| Article | Year |
|---|---|
[Role of hypothalamic adenosinergic systems in regulating states of wakefulness in the rat].
Topics: Adenine; Adenosine; Animals; Hypothalamus; Hypothalamus, Posterior; Immunosuppressive Agents; Male; Piperazines; Rats; Rats, Inbred Strains; Sleep; Wakefulness | 1989 |
Adenosine transformation by human red blood cell membranes.
Topics: Adenine; Adenosine; Erythrocyte Membrane; Humans; Piperazines | 1995 |
Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats.
Topics: Adenine; Adenosine; Adenosine Diphosphate; Animals; Antihypertensive Agents; Carbon Monoxide; Dipyridamole; Diuretics; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Gene Expression; Hypoxia; Kidney; Male; Oxygen; Phenethylamines; Phosphodiesterase Inhibitors; Piperazines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; RNA, Messenger; Theophylline; Vasodilator Agents; Xanthines | 1997 |